AZD6234
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
AstraZeneca · Phase 1 · Completed · Enrollment 104
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.